title: Macular recovery time, diabetic retinopathy, and clinical variables after 7 years of improved glycemic control.
abstract: Effects of long-term improved glucose control on neurosensory retinal function are investigated. Changes in macular recovery of nyctometry (photostress) are assessed in 45 insulin-dependent diabetic patients between study start and after 7 years prospective follow-up (the Oslo Study). Intensified insulin treatment improved glycosylated hemoglobin (HbA1) from 11.7 +/- 2.2% at start to a 7-year cumulative mean of 9.5 +/- 1.5% (p less than 0.0001). Improved macular recovery performance was observed in patients with 7-year mean HbA1 below 10%, compared to a worsening in those above 10% (p less than 0.001-0.02), and non-proliferative retinopathy progressed less in those with HbA1 below 10%, than in those above (p less than 0.01). Macular recovery at study start did not predict progression or outcome of retinopathy 7 years later. Intraocular pressure fell during the 7 years (p less than 0.001) and was cross-sectionally negatively correlated to macular recovery at the 7-year end-point (p less than 0.001-0.002). Macular recovery was not related to age, duration of diabetes, systemic blood pressure, or urinary albumin excretion level. The study indicates that severity of retinopathy, glycemic control and intraocular pressure are interesting covariants to neurosensory dysfunction in diabetes. Furthermore, the study suggests a critical level of long-term blood glucose or retinopathy, or both, above which neurosensory function of macular recovery is significantly reduced.
authors.affiliation: Department of Ophthalmology, Trondheim University Hospital, Norway.
authors.forename: O
authors.initials: O
authors.lastname: Brinchmann-Hansen
authors.forename: K
authors.initials: K
authors.lastname: Dahl-Jørgensen
authors.forename: K F
authors.initials: KF
authors.lastname: Hanssen
authors.forename: L
authors.initials: L
authors.lastname: Sandvik
mesh_terms: D000328:Adult; D001786:Blood Glucose; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology / Q000517:prevention & control*; D003930:Diabetic Retinopathy / Q000503:physiopathology*; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007003:Hypoglycemia / Q000503:physiopathology / Q000517:prevention & control*; D007429:Intraocular Pressure; D008027:Light; D008266:Macula Lutea / Q000503:physiopathology*; D008297:Male; D011446:Prospective Studies; D011601:Psychophysics; D012160:Retina / Q000503:physiopathology*; D014792:Visual Acuity
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin